✦ LIBER ✦

Economic evaluation of Gemzar/cisplatin relative to other cisplatin based treatments for non small cell lung (NSCLC) cancer in the UK

✍ Scribed by N. Botwood; J. McKendrick; M. Aristides; M. Lees; N. Maniadakis; W. Wein; D. Stephenson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinorelbine (VB)+ cisplatin (DDP)+ etopo

✍ Marangolo, M.; Intini, C. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Is cisplatin necessary for the treatment

✍ Kubota, K; Nishiwaki, Y; Yokoyama, A; Yoneda, S; Tamura, T; Watanabe, K; Saijo, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 101 KB

CN5 EXPLORATORY ECONOMIC EVALUATION OF A

✍ M Gyldmark; U Gatzemeier; M Nicolson; N Latimer; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCNI8 A COST COMPARISON OF GEMZAR PLUS C

✍ A Kielhorn; G Stynes; S Bhalla; D Tilden 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Phase II trial of mitomycin, vindesine a

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 99 KB

The role of three cisplatin-based chemot

✍ Jirillo, A.; Pavanato, G.; Lonardi, F.; Bonciarelli, G.; Balli, M. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 123 KB